Literature DB >> 19685026

Second malignant neoplasms after childhood cancer in Germany--results from the long-term follow-up of the German Childhood Cancer Registry.

Peter Kaatsch1, Desiree Debling, Maria Blettner, Claudia Spix.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19685026     DOI: 10.1007/s00066-009-1005-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  14 in total

1.  German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results.

Authors:  Tobias Bölling; Andreas Schuck; Hildegard Pape; Christian Rübe; Frank-Michael Meyer; Carmen Martini; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Jörn D Beck; Thorsten Langer; Marios Paulides; Normann Willich
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

2.  Childhood malignancies in Germany--methods and results of a nationwide registry.

Authors:  P Kaatsch; G Haaf; J Michaelis
Journal:  Eur J Cancer       Date:  1995-06       Impact factor: 9.162

3.  Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.

Authors:  L Löning; M Zimmermann; A Reiter; P Kaatsch; G Henze; H Riehm; M Schrappe
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

4.  Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.

Authors:  G Schellong; M Riepenhausen
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

5.  Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

Authors:  Anja Borgmann; Christina Zinn; Reinhard Hartmann; Ralf Herold; Peter Kaatsch; Gabriele Escherich; Anja Möricke; Günter Henze; Arend von Stackelberg
Journal:  Eur J Cancer       Date:  2007-11-05       Impact factor: 9.162

6.  Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.

Authors:  Peter Kaatsch; Irene Reinisch; Claudia Spix; Frank Berthold; Gritta Janka-Schaub; Andreas Mergenthaler; Jörg Michaelis; Maria Blettner
Journal:  Cancer Causes Control       Date:  2009-03-05       Impact factor: 2.506

7.  The cohort of long-term survivors at the German childhood cancer registry.

Authors:  D Debling; C Spix; M Blettner; J Michaelis; P Kaatsch
Journal:  Klin Padiatr       Date:  2008-10-23       Impact factor: 1.349

Review 8.  Second tumors after oncologic treatment.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

9.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816

10.  Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain.

Authors:  H C Jenkinson; M M Hawkins; C A Stiller; D L Winter; H B Marsden; M C G Stevens
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

View more
  9 in total

1.  ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.

Authors:  F Wenz; Y Abo-Madyan; G Welzel; F A Giordano
Journal:  Strahlenther Onkol       Date:  2012-08       Impact factor: 3.621

2.  Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case-control study.

Authors:  Ulrike Hennewig; Peter Kaatsch; Maria Blettner; Claudia Spix
Journal:  Radiat Environ Biophys       Date:  2014-05-27       Impact factor: 1.925

3.  Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?

Authors:  B Knäusl; C Lütgendorf-Caucig; J Hopfgartner; K Dieckmann; L Kurch; T Pelz; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

4.  Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.

Authors:  C Blattmann; S Oertel; M Thiemann; K J Weber; P Schmezer; O Zelezny; R Lopez Perez; A E Kulozik; J Debus; V Ehemann
Journal:  Strahlenther Onkol       Date:  2012-01-18       Impact factor: 3.621

5.  Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Authors:  Frank Heinzelmann; Daniela Thorwarth; Ulf Lamprecht; Theodor W Kaulich; Jörg Fuchs; Guido Seitz; Martin Ebinger; Rupert Handgretinger; Michael Bamberg; Martin Weinmann
Journal:  Strahlenther Onkol       Date:  2011-10-29       Impact factor: 3.621

Review 6.  Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.

Authors:  Klaus Müller; Isabella Zwiener; Helmut Welker; Eberhard Maass; Rudolf Bongartz; Frank Berthold; Torsten Pietsch; Monika Warmuth-Metz; André von Bueren; Stefan Rutkowski
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

7.  Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.

Authors:  Francesco Felicetti; Nicoletta Fortunati; Diego Garbossa; Eleonora Biasin; Roberta Rudà; Dino Daniele; Emanuela Arvat; Andrea Corrias; Franca Fagioli; Enrico Brignardello
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-22       Impact factor: 4.553

Review 8.  Review of risk factors of secondary cancers among cancer survivors.

Authors:  Charlotte Demoor-Goldschmidt; Florent de Vathaire
Journal:  Br J Radiol       Date:  2018-09-12       Impact factor: 3.039

9.  Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014.

Authors:  Peter Scholz-Kreisel; Peter Kaatsch; Claudia Spix; Heinz Schmidberger; Manuela Marron; Desiree Grabow; Cornelia Becker; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2018-06-08       Impact factor: 5.594

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.